TrialLancet (London, England)2024

Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.

Sandra P D'Angelo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.